Literature DB >> 28301902

The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery.

Masahiro Hasegawa1, Hideo Wada2, Shinichi Miyazaki1, Toshio Yamaguchi1, Hiroki Wakabayashi1, Naoki Fujimoto2, Takeshi Matsumoto3, Kohshi Ohishi3, Akane Sakaguchi4, Norikazu Yamada5, Masaaki Ito5, Yoshiki Yamashita6, Naoyuki Katayama6, Kaname Nakatani4, Akihiro Sudo1.   

Abstract

OBJECTIVE: The cutoff values of fibrin-related markers (FRMs) diagnosing or predicting the occurrence of a venous thromboembolism (VTE) were evaluated.
MATERIALS AND METHODS: Fibrin-related markers such as fibrin monomer complex (FMC), D-dimer, and fibrinogen and fibrin degradation products (FDPs) before surgery were measured in 326 patients undergoing orthopedic surgery to diagnose subclinical VTE or predict postoperative VTE.
RESULTS: Although the FMC, D-dimer, and FDP levels were all useful for the diagnosis of acute VTE, the FDP level was not useful for diagnosing subclinical VTE or predicting postoperative VTE. The results of several D-dimer assays closely correlated with other D-dimer assays. There were various cutoff ranges for diagnosing or predicting VTE. Some D-dimer assays were useful for diagnosing low levels of D-dimer and others were useful for diagnosing moderate to high D-dimer levels. Increased D-dimer levels were useful for diagnosing acute (cutoff values: 2.0-5.9 μg/mL) or about 10% of subclinical VTE (cutoff values: 3.4-5.3 μg/mL), for predicting about 10% of postoperative VTE (cutoff values: 3.4-5.3 μg/mL), and for excluding VTE.
CONCLUSION: Although increased D-dimer levels were useful for diagnosing subclinical VTE and predicting the risk of VTE, there were various cutoff values for the diagnosis or prediction of VTE.

Entities:  

Keywords:  D-dimer; FMC; FRMs; VTE; orthopedic surgery

Mesh:

Substances:

Year:  2016        PMID: 28301902      PMCID: PMC6714636          DOI: 10.1177/1076029616674824

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  29 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.

Authors:  C E Dempfle; S Zips; H Ergül; D L Heene
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

3.  Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.

Authors:  J A Heit; C G Elliott; A A Trowbridge; B F Morrey; M Gent; J Hirsh
Journal:  Ann Intern Med       Date:  2000-06-06       Impact factor: 25.391

4.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

5.  Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.

Authors:  C W Colwell; D K Collis; R Paulson; J W McCutchen; G T Bigler; S Lutz; M E Hardwick
Journal:  J Bone Joint Surg Am       Date:  1999-07       Impact factor: 5.284

6.  Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.

Authors:  F Piovella; C-J Wang; H Lu; K Lee; L H Lee; W C Lee; A G G Turpie; A S Gallus; A Planès; R Passera; A Rouillon
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

7.  Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis.

Authors:  H Wada; T Kobayashi; Y Abe; T Hatada; N Yamada; A Sudo; A Uchida; T Nobori
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

Review 8.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

10.  Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.

Authors:  Alexander T Cohen; Giancarlo Agnelli; Frederick A Anderson; Juan I Arcelus; David Bergqvist; Josef G Brecht; Ian A Greer; John A Heit; Julia L Hutchinson; Ajay K Kakkar; Dominique Mottier; Emmanuel Oger; Meyer-Michel Samama; Michael Spannagl
Journal:  Thromb Haemost       Date:  2007-10       Impact factor: 5.249

View more
  4 in total

1.  Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury.

Authors:  Pierre Esnault; Quentin Mathais; Erwan D'Aranda; Ambroise Montcriol; Mickaël Cardinale; Pierre-Julien Cungi; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Eric Meaudre
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

2.  Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.

Authors:  Yuying Cheng; Jian Liu; Yu Su; Huiru Zhao; Yujing Zhao; Meng Wen; Shan Lu; Wenjie Zhang; Jun Wu
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

3.  Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients.

Authors:  Yuhuko Ichkawa; Hideo Wada; Minoru Ezaki; Motoko Tanaka; Shinya Hiromori; Katsuya Shiraki; Isao Moritani; Akitaka Yamamoto; Haruhiko Tashiro; Hideto Shimpo; Motomu Shimaoka
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

4.  D-dimer kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases.

Authors:  Nozomi Ikeda; Hideo Wada; Yuhuko Ichikawa; Minoru Ezaki; Motoko Tanaka; Shinya Hiromori; Katsuya Shiraki; Isao Moritani; Akitaka Yamamoto; Hideto Shimpo; Motomu Shimaoka
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.